Pos0764 Eular Recommendation-based Quality Indicators (qis) for Systemic Lupus Erythematosus (sle): Elaboration, Final Set, Performance and Initial Validation
Year: 2021
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Authors: K. Chavatza, M. Kostopoulou, D. Nikolopoulos, O. Gioti, K. Togia, S. Flouda, N. Kapsala, M. Kosmetatou, G.S. Moysidou, A. Grivas, A. Pieta, A. Ntourou, P. Rapsomaniki, T. Gerogianni, D. Tseronis, M. Aggelakos, T. Karageorgas, P. Katsimpri, L. Andreoli, M. Aringer, J.N. Boletis, A. Doria, F. Houssiau, D. Jayne, M. Mosca, E. Svenungsson, A. Tincani, G. Bertsias, A. Fanouriakis, D. Boumpas
Institutions: National and Kapodistrian University of Athens, General Hospital of Athens G. Genimatas, General Hospital Asklepieio Voulas, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia, Technische Universität Dresden, University of Padua, Cliniques Universitaires Saint-Luc, UCLouvain, Addenbrooke's Hospital, University of Pisa, Karolinska University Hospital, Karolinska Institutet, University Hospital of Heraklion, Hospital General de Agudos Dr. Enrique Tornú, Istanbul University, Biomedical Research Foundation of the Academy of Athens
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: systemic lupus erythematosus, quality indicators, EULAR recommendations, quality of care, lupus nephritis, hydroxychloroquine, glucocorticoids, disease activity monitoring, cardiovascular risk modification, vaccination, osteoporosis prevention, disease flares, organ damage, immunosuppressive therapy
Open Access status: bronze
OpenAlex ID: W3165717543
